Data protection Impressum

Newsroom

Vaud-based life sciences company Limula has secured CHF 6.2 million to democratize access to life-saving cell and gene therapies.

Limula secures CHF 6.2 million to advance automated cell therapy platform

21 May 2024

An EPFL research project has developed a method based on machine learning to quickly and accurately search large databases, leading to the discovery of 14 new materials for solar cells.

EPFL uses machine learning to discover new solar-cell materials

21 May 2024

Elythor emerged as the top winner of the 22nd edition of the Prix Entreprendre Lausanne Région (PERL) awards.

Elythor wins top honors at PERL Awards 2024 for its innovative drone technology

21 May 2024

HeroSupport and Calico Biosystems join Tech4Eva, a six-month equity-free accelerator dedicated to advancing women’s health technologies globally.

HeroSupport and Calico Biosystems selected for the Tech4Eva accelerator program

15 May 2024

ORamaVR is set to enhance its innovative VR solutions for medical training with new support from Innosuisse's Scale-up Coaching program.

ORamaVR receives Scale-up Award from Innosuisse to accelerate growth

15 May 2024

Yuon Control successfully closed a first financing round to accelerate market adoption of their innovative and predictive heating control software to optimize heating networks.

Yuon Control secures funding to boost innovation in the heating sector

14 May 2024

Bernese start-up Green-Y Energy has successfully closed a CHF 3 million investment round to advance the market launch of its innovative compressed air energy storage system.

CHF 3 million for Green-Y Energy’s compressed air energy storage solution

14 May 2024

Geneva-based digital private bank Alpian has successfully closed its Series C funding round, securing a total of CHF 76 million to accelerate its growth and enhance its digital wealth management services.

Digital bank Alpian secures CHF 76 million to drive growth and innovation

14 May 2024

Takeda will receive an exclusive option to license AC Immune's ACI-24.060, a breakthrough therapy to combat the progression of Alzheimer's disease, for an upfront payment of USD 100 million and potential milestone payments of USD 2.1 billion.

AC Immune and Takeda sign USD 100 million deal to treat Alzheimer’s disease

13 May 2024

Key players from Western Switzerland are coming together to strengthen the region's commitment to renewable hydrogen production, which will not only address global climate change, but also innovate the industrial and energy sectors.

Hydrogen technology advancements in Western Switzerland

13 May 2024

1 … 28 29 30 31 32 33 34 35 36 … 140